1. Home
  2. CYTK vs ANF Comparison

CYTK vs ANF Comparison

Compare CYTK & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ANF
  • Stock Information
  • Founded
  • CYTK 1997
  • ANF 1892
  • Country
  • CYTK United States
  • ANF United States
  • Employees
  • CYTK N/A
  • ANF N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ANF Clothing/Shoe/Accessory Stores
  • Sector
  • CYTK Health Care
  • ANF Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • ANF Nasdaq
  • Market Cap
  • CYTK 4.6B
  • ANF 3.8B
  • IPO Year
  • CYTK 2004
  • ANF 1996
  • Fundamental
  • Price
  • CYTK $58.45
  • ANF $68.43
  • Analyst Decision
  • CYTK Buy
  • ANF Buy
  • Analyst Count
  • CYTK 16
  • ANF 10
  • Target Price
  • CYTK $76.73
  • ANF $119.30
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • ANF 2.0M
  • Earning Date
  • CYTK 11-05-2025
  • ANF 11-25-2025
  • Dividend Yield
  • CYTK N/A
  • ANF N/A
  • EPS Growth
  • CYTK N/A
  • ANF 13.04
  • EPS
  • CYTK N/A
  • ANF 10.58
  • Revenue
  • CYTK $85,738,000.00
  • ANF $5,099,754,000.00
  • Revenue This Year
  • CYTK $363.61
  • ANF $7.63
  • Revenue Next Year
  • CYTK $64.08
  • ANF $3.98
  • P/E Ratio
  • CYTK N/A
  • ANF $6.48
  • Revenue Growth
  • CYTK 2635.74
  • ANF 9.34
  • 52 Week Low
  • CYTK $29.31
  • ANF $65.40
  • 52 Week High
  • CYTK $63.86
  • ANF $167.71
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 60.20
  • ANF 20.52
  • Support Level
  • CYTK $58.84
  • ANF $72.90
  • Resistance Level
  • CYTK $63.86
  • ANF $73.55
  • Average True Range (ATR)
  • CYTK 2.52
  • ANF 2.33
  • MACD
  • CYTK -0.26
  • ANF -1.00
  • Stochastic Oscillator
  • CYTK 47.43
  • ANF 1.41

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ANF Abercrombie & Fitch Company

Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.

Share on Social Networks: